| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +3.8% | +65.6% |
| Cost of Revenue | $3.8M | +16.3% | +167.6% |
| R&D Expense | $676K | +0.1% | +131.6% |
| SG&A Expense | $2.1M | +7.4% | -24.9% |
| Operating Income | -$470K | -1119.8% | +41.0% |
| Pre-tax Income | -$170K | -149.9% | +43.5% |
| Income Tax | -$19K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.7M | -13.2% | +72.1% |
| Short-term Investments | $23.6M | -22.2% | -49.5% |
| Accounts Receivable | $5.4M | +3.0% | +53.0% |
| Current Assets | $39.4M | -15.4% | -29.5% |
| Total Assets | $41.3M | -14.9% | -28.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$336K | — | — |
| Investing Cash Flow | $7.8M | — | — |
| Financing Cash Flow | -$7.4M | — | — |
| -116.1% |
| +80.6% |
| Net Income | -$151K | -167.3% | +26.2% |
| EPS (Basic) | $0.00 | -100.0% | +100.0% |
| EPS (Diluted) | $0.00 | -100.0% | +100.0% |
| $10.2M |
| -41.9% |
| -66.2% |
| Total Liabilities | $10.2M | -41.9% | -66.8% |
| Stockholders' Equity | $31.1M | +0.4% | +15.6% |